Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

TheraSense completes $50mm private placement

12 Apr 2001

Executive Summary

TheraSense (diabetes) has completed a $50mm fourth round private placement led by Disetronic Holding AG--with which TheraSense has a distribution agreement--and existing investors Brentwood Associates, Crown Advisors, Dephi Ventures, Equity Group Investments, InterWest Partners, Lehman Brothers Venture Capital, Lurie Group, MedVentures, MJG Partners, and Sequoia Capital.
Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Diagnostic Equipment & Supplies
  • In Vitro Diagnostics
    • Glucose Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By